Dagi BenNoon - Inspira Technologies CEO CoFounder
| IINN Stock | USD 1.06 0.07 6.19% |
Insider
Dagi BenNoon is CEO CoFounder of Inspira Technologies Oxy
| Age | 48 |
| Address | 2 Ha-Tidhar Street, Ra'anana, Israel, 4366504 |
| Phone | 972 4 6230333 |
| Web | https://inspira-technologies.com |
Inspira Technologies Management Efficiency
The company has return on total asset (ROA) of (0.5953) % which means that it has lost $0.5953 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1654) %, meaning that it created substantial loss on money invested by shareholders. Inspira Technologies' management efficiency ratios could be used to measure how well Inspira Technologies manages its routine affairs as well as how well it operates its assets and liabilities. As of the 29th of December 2024, Return On Tangible Assets is likely to drop to -1.27. In addition to that, Return On Capital Employed is likely to drop to -2.01. At this time, Inspira Technologies' Total Assets are very stable compared to the past year. As of the 29th of December 2024, Net Tangible Assets is likely to grow to about 15.5 M, while Non Current Assets Total are likely to drop about 896.9 K.Similar Executives
| Showing other executives | INSIDER Age | ||
| Harold MD | NanoVibronix | 70 | |
| Shunichi Kuroda | Bone Biologics Corp | N/A | |
| Xuan Kong | NeuroMetrix | N/A | |
| CPA CPA | NanoVibronix | 68 | |
| Kendra Wong | LENSAR Inc | 44 | |
| Sanjay Ahuja | Tivic Health Systems | N/A | |
| David MD | Sight Sciences | 54 | |
| Kirk Huntsman | Vivos Therapeutics | 66 | |
| Robert Moccia | STRATA Skin Sciences | 65 | |
| Mark Saxton | Neuropace | 59 | |
| John Ordway | Sight Sciences | N/A | |
| Andre Marquette | Neuropace | N/A | |
| Veronica Cai | Tivic Health Systems | 48 | |
| Kenneth CPA | Bluejay Diagnostics | 44 | |
| Darrell Rigel | STRATA Skin Sciences | 73 | |
| RaeAnn Byrnes | Vivos Therapeutics | N/A | |
| Jennifer Ernst | Tivic Health Systems | 56 | |
| Reay Brown | Sight Sciences | N/A | |
| Chi Nguyen | Neuropace | 47 | |
| Paul Badawi | Sight Sciences | 49 | |
| Danielle Watson | Heart Test Laboratories | 42 | |
Management Performance
| Return On Equity | -1.17 | ||||
| Return On Asset | -0.6 |
Inspira Technologies Oxy Leadership Team
Elected by the shareholders, the Inspira Technologies' board of directors comprises two types of representatives: Inspira Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inspira. The board's role is to monitor Inspira Technologies' management team and ensure that shareholders' interests are well served. Inspira Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inspira Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joe Hayon, President CoFounder | ||
| Rony Aloni, Marketing Mang | ||
| Odelya Dekel, HR Mang | ||
| Adi Shmueli, Director Marketing | ||
| Dagi BenNoon, CEO CoFounder | ||
| Yafit Tehila, Chief Officer | ||
| Adi Nir, Chief Officer | ||
| Daniella YeheskelyHayon, Chief Officer | ||
| Avi Shabtai, COO Development | ||
| Meshira Greenberg, Administrative Manager |
Inspira Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Inspira Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.17 | ||||
| Return On Asset | -0.6 | ||||
| Current Valuation | 16.82 M | ||||
| Shares Outstanding | 18.5 M | ||||
| Shares Owned By Insiders | 8.88 % | ||||
| Shares Owned By Institutions | 0.84 % | ||||
| Number Of Shares Shorted | 279.88 K | ||||
| Price To Book | 3.67 X | ||||
| EBITDA | (10.87 M) | ||||
| Net Income | (11.29 M) |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspira Technologies Oxy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inspira Technologies. If investors know Inspira will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inspira Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.78) | Return On Assets (0.60) | Return On Equity (1.17) |
The market value of Inspira Technologies Oxy is measured differently than its book value, which is the value of Inspira that is recorded on the company's balance sheet. Investors also form their own opinion of Inspira Technologies' value that differs from its market value or its book value, called intrinsic value, which is Inspira Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inspira Technologies' market value can be influenced by many factors that don't directly affect Inspira Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inspira Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inspira Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inspira Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.